AzTrials
AzTrials

Achilles Tendon InjuryNCT02532595

TDN, Manual Therapy and Exercise For the Management of Achilles Tendinopathy

A study testing manual therapy and exercise and trigger point dry needling in people with Achilles Tendon Injury, run by Nova Southeastern University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Conflicting evidence exists regarding the recommendations from the Orthopaedic section of the American Physical Therapy Association for treatment of Achilles tendinitis. Trigger point dry needling is effective in reducing pain in several body regions, but no published (TDN) studies are found reporting the effect on… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Achilles Tendon Injury
What is being tested?
manual therapy and exercise and trigger point dry needling
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteUnited States
Study dates
May 2015to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • pain onset greater than 4 weeks
  • primary region of pain 2-6 cm proximal to the insertion on the calcaneus
  • read and write in english

Who cannot join

  • Fear of needles or unwilling to have needling performed due to fear or personal beliefs.
  • Vascular or sensory disturbances in the lower leg which include but is not limited to injury to the nerve root or peripheral nerve in the affected lower leg, inflammatory diseases, bleeding or clotting disorders, lymphedema, peripheral vascular or peripheral arterial disease. Diabetes is included in this group due to the progressive changes to the sensation and circulation in the lower extremities.
  • Recent infection.
  • Previous surgery to the foot/ankle.
  • Steroid by injection or transdermal delivery to the posterior heel within three months.
  • Full rupture of the Achilles tendon.
  • Pregnant or may be pregnant.
  • Participants with a work related injury insured by the bureau of worker's compensation or involved in litigation related to injury of the lower leg, foot or ankle.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Breakthrough Physical Therapy

    Fayetteville, North Carolina, 28311

Other trials in United States

About this study

Official title: Trigger Point Dry Needling, Manual Therapy and Exercise vs Manual Therapy and Exercise For the Management of Achilles Tendinopathy

Conflicting evidence exists regarding the recommendations from the Orthopaedic section of the American Physical Therapy Association for treatment of Achilles tendinitis. Trigger point dry needling is effective in reducing pain in several body regions, but no published (TDN) studies are found reporting the effect on Achilles tendinopathy. The purpose of this study is to investigate whether a treatment program performed including TDN, manual therapy and exercise will result in a significant improvement in pain, strength and function compared to a treatment program including manual therapy and exercise for Achilles tendinopathy. Subjects with Achilles tendinopathy that receive treatment including TDN, manual therapy and exercise will demonstrate a significant improvement in pain, strength and functional outcomes compared to the group that receives manual therapy and exercise.

Read the detailed description

This study is a randomized controlled trial, pretest-posttest control group design comparing the effect of TDN, manual therapy and exercise to manual therapy and exercise on human subjects with Achilles tendinopathy following eight treatments in four weeks and a follow up examination at three months.

Being tested
manual therapy and exercise, trigger point dry needling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • manual therapy and exerciseProcedure or surgery

    soft tissue mobilization, stretches, concentric and eccentric strengthening

  • trigger point dry needlingProcedure or surgery

    trigger point dry needling to trigger points located in the gastrocnemius, soleus and tibialis posterior

Study groups in NCT02532595
Study groupRoleWhat they receive
Group 1 manual therapy and exerciseActive comparatormanual therapy with soft tissue mobilization to trigger points in the gastrocnemius, soleus, and tibialis posterior; exercise including stretching, concentric and eccentric exercises to the hip, triceps surae, tibialis posterior and foot intrinsics.
Receives: Procedure: manual therapy and exercise
Group 2 TDN, manual therapy and exerciseExperimentaltrigger point dry needling (TDN) to trigger points in the gastrocnemius, soleus and tibialis posterior; manual therapy with soft tissue mobilization to trigger points in the gastrocnemius, soleus, and tibialis posterior; exercise including stretching, concentric and eccentric exercises to the hip, triceps surae, tibialis posterior and foot intrinsics.
Receives: Procedure: manual therapy and exercise; Procedure: trigger point dry needling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Functional Activity Level from baseline with the Functional Ankle Ability Measure

    Measured: 4 weeks

  2. Change in Functional Activity Level from baseline with the Functional Ankle Ability Measure

    Measured: 3 months

  3. Change in Pain from Baseline with the Numeric Pain Rating Scale

    Measured: 4 weeks

  4. Change in Pain from Baseline with the Numeric Pain Rating Scale

    Measured: 3 months

  5. Change in Fear of Activity from baseline with the Tampa Scale of Kinesiophobia

    Measured: 4 weeks

  6. Change in Fear of Activity from baseline with the Tampa Scale of Kinesiophobia

    Measured: 3 months

  7. Change in Pain from baseline with the Global Rating of Change

    Measured: 4 weeks

  8. Change in Pain from baseline with the Global Rating of Change

    Measured: 3 months

  9. Change in Pain from baseline with the Pain Pressure Threshold Measure

    Primary site of pain on the Achilles tendon. All measurements taken with the Wagner FPK 20 Algometer.

    Measured: 4 weeks

  10. Change in Pain from baseline with the Pain Pressure Threshold Measure

    Primary site of pain on the Achilles tendon. All measurements taken with the Wagner FPK 20 Algometer.

    Measured: 3 months

  11. Change in strength from baseline with the Muscle Endurance Test for single leg heel raise

    Measured: 4 weeks

  12. Change in strength from baseline with the Muscle Endurance Test for single leg heel raise

    Measured: 3 months

Secondary outcomes (5)
  1. Age

    Demographic information -

    Measured: baseline

  2. Height

    Demographic information

    Measured: baseline

  3. Weight

    Demographic information

    Measured: baseline

  4. Gender

    Demographic information

    Measured: baseline

  5. Duration of Pain

    Demographic information

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2015 (estimated)
  2. Study startMay 2015
  3. Primary completion31 Dec 2018
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02532595
Sponsor's protocol ID
03261504F
Status last verified
Jan 2020
First submitted
14 Aug 2015
Last updated
30 Jun 2021
Results posted
No
Data monitoring committee
No

Publications

  • Carcia CR, Martin RL, Houck J, Wukich DK; Orthopaedic Section of the American Physical Therapy Association. Achilles pain, stiffness, and muscle power deficits: achilles tendinitis. J Orthop Sports Phys Ther. 2010 Sep;40(9):A1-26. doi: 10.2519/jospt.2010.0305. No abstract available.

    PubMed 20805627
  • Ga H, Choi JH, Park CH, Yoon HJ. Dry needling of trigger points with and without paraspinal needling in myofascial pain syndromes in elderly patients. J Altern Complement Med. 2007 Jul-Aug;13(6):617-24. doi: 10.1089/acm.2006.6371.

    PubMed 17718644
  • Fernandez-Carnero J, La Touche R, Ortega-Santiago R, Galan-del-Rio F, Pesquera J, Ge HY, Fernandez-de-Las-Penas C. Short-term effects of dry needling of active myofascial trigger points in the masseter muscle in patients with temporomandibular disorders. J Orofac Pain. 2010 Winter;24(1):106-12.

    PubMed 20213036
  • Gonzalez-Iglesias J, Cleland JA, del Rosario Gutierrez-Vega M, Fernandez-de-las-Penas C. Multimodal management of lateral epicondylalgia in rock climbers: a prospective case series. J Manipulative Physiol Ther. 2011 Nov;34(9):635-42. doi: 10.1016/j.jmpt.2011.09.003. Epub 2011 Oct 21.

    PubMed 22018577
  • Tekin L, Akarsu S, Durmus O, Cakar E, Dincer U, Kiralp MZ. The effect of dry needling in the treatment of myofascial pain syndrome: a randomized double-blinded placebo-controlled trial. Clin Rheumatol. 2013 Mar;32(3):309-15. doi: 10.1007/s10067-012-2112-3. Epub 2012 Nov 9.

    PubMed 23138883
  • Cotchett MP, Munteanu SE, Landorf KB. Effectiveness of trigger point dry needling for plantar heel pain: a randomized controlled trial. Phys Ther. 2014 Aug;94(8):1083-94. doi: 10.2522/ptj.20130255. Epub 2014 Apr 3.

    PubMed 24700136
  • Llamas-Ramos R, Pecos-Martin D, Gallego-Izquierdo T, Llamas-Ramos I, Plaza-Manzano G, Ortega-Santiago R, Cleland J, Fernandez-de-Las-Penas C. Comparison of the short-term outcomes between trigger point dry needling and trigger point manual therapy for the management of chronic mechanical neck pain: a randomized clinical trial. J Orthop Sports Phys Ther. 2014 Nov;44(11):852-61. doi: 10.2519/jospt.2014.5229. Epub 2014 Sep 30.

    PubMed 25269764
  • Osborne NJ, Gatt IT. Management of shoulder injuries using dry needling in elite volleyball players. Acupunct Med. 2010 Mar;28(1):42-5. doi: 10.1136/aim.2009.001560.

    PubMed 20351377
  • Jayaseelan DJ, Moats N, Ricardo CR. Rehabilitation of proximal hamstring tendinopathy utilizing eccentric training, lumbopelvic stabilization, and trigger point dry needling: 2 case reports. J Orthop Sports Phys Ther. 2014 Mar;44(3):198-205. doi: 10.2519/jospt.2014.4905. Epub 2013 Nov 21.

    PubMed 24261928
  • Koszalinski A, Flynn T, Hellman M, Cleland JA. Trigger point dry needling, manual therapy and exercise versus manual therapy and exercise for the management of Achilles tendinopathy: a feasibility study. J Man Manip Ther. 2020 Sep;28(4):212-221. doi: 10.1080/10669817.2020.1719299. Epub 2020 Feb 12.

    PubMed 32048918

Questions about this trial

What is this clinical trial studying?

A study testing manual therapy and exercise and trigger point dry needling in people with Achilles Tendon Injury, run by Nova Southeastern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Functional Activity Level from baseline with the Functional Ankle Ability Measure (time frame: 4 weeks). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02532595, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in